Hi-Plex for high-throughput mutation screening: Application to the breast cancer susceptibility gene PALB2

BMC Medical Genomics

Volumn 6, Issue 1, 2013, Pages

  Nguyen Dumont, Tú ^a   Teo, Zhi L ^a   Pope, Bernard J ^a,b   Hammet, Fleur ^a   Mahmoodi, Maryam ^a   Tsimiklis, Helen ^a   Sabbaghian, Nelly ^c   Tischkowitz, Marc ^d   Foulkes, William D ^c,e   Giles, Graham G ^a,f   Hopper, John L ^a   Southey, Melissa C ^a   Park, Daniel J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Victorian Life Sciences Computation Initiative   (Australia)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e MCGILL UNIVERSITY   (Canada)

^f CANCER EPIDEMIOLOGY CENTRE   (Australia)

Author keywords

Hi Plex; Massively parallel sequencing; Molecular diagnostics; Mutation screening; PALB2

Indexed keywords

DNA;

AMPLICON; ARTICLE; BREAST CANCER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; GENE LIBRARY; GENE MUTATION; GENETIC CODE; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; NUCLEOTIDE SEQUENCE; PALB2 GENE; PRIORITY JOURNAL;

BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION; NUCLEAR PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 84887388747     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-6-48     Document Type: Article

References (8)

1. A high-plex PCR approach for massively parallel sequencing. Nguyen-Dumont T, Pope BJ, Hammet F, Southey MC, Park DJ, Biotechniques 2013 55 69 74 23931594
2. Cross-platform compatibility of Hi-Plex, a streamlined approach for targeted massively parallel sequencing. Nguyen-Dumont T, Pope BJ, Hammet F, Mahmoodi M, Tsimiklis H, Southey MC, Park DJ, Anal Biochem 2013 442 2 127 129 10.1016/j.ab.2013.07.046 23933242
3. Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer. Tischkowitz M, Sabbaghian N, Ray AM, Lange EM, Foulkes WD, Cooney KA, Prostate 2008 68 675 678 10.1002/pros.20729 18288683 (Pubitemid 351614645)
4. A PALB2 mutation associated with high risk of breast cancer. Southey MC, Teo ZL, Dowty JG, Odefrey FA, Park DJ, Tischkowitz M, Sabbaghian N, Apicella C, Byrnes GB, Winship I, et al. Breast Cancer Res 2010 12 109 10.1186/bcr2796 21182766
5. Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families. Teo ZL, Park DJ, Provenzano E, Chatfield CA, Odefrey FA, Nguyen-Dumont T, Dowty JG, Hopper JL, Winship I, Goldgar DE, Southey MC, Breast Cancer Res 2013 15 17 10.1186/bcr3392 23448497
6. Fast gapped-read alignment with Bowtie 2. Langmead B, Salzberg SL, Nat Methods 2012 9 357 359 10.1038/nmeth.1923 22388286
7. BEDTools: a flexible suite of utilities for comparing genomic features. Quinlan AR, Hall IM, Bioinformatics 2010 26 841 842 10.1093/bioinformatics/ btq033 20110278
8. Next-generation sequencing for cancer diagnostics: a practical perspective. Meldrum C, Doyle MA, Tothill RW, Clin Biochem Rev 2011 32 177 195 22147957